Tissue Product Jurisdiction One Focus Of Intercenter Agreement Talks
This article was originally published in The Gray Sheet
Executive Summary
Tissue-engineered products have been the focus of early discussions related to updating FDA's intercenter agreement on jurisdiction of device-related products, according to agency staff.